Biohacking

SR9009 – Stenabolic

A Comprehensive Guide to SR9009 (Stenabolic)

Performance

Cellular Health

SR9009 (Stenabolic) is an experimental compound that targets metabolic pathways to potentially improve endurance and fat loss, though its effects remain under investigation.

We cover emerging biohacking topics because our readers ask about them. This is not guidance to self-experiment. This article is educational and not intended to diagnose, treat, or suggest any specific intervention, and should not replace qualified medical advice.

SR9009 is a compound that may enhance endurance and metabolism.

We recognize growing interest in biohacking and experimental-stage substances. This article discusses an experimental method that may not be suitable for DIY use; any consideration belongs with qualified supervision.

Why Is SR9009 Gaining Attention?

SR9009 is gaining attention because it activates Rev-Erb proteins that regulate circadian rhythm and metabolism, showing potential for fat loss and endurance improvement.

SR9009, also known as Stenabolic, is gaining attention for its link to circadian rhythm and metabolism. It activates a protein that influences how the body processes energy and fat. Researchers are intrigued by its potential to mimic some benefits of exercise at a cellular level. Athletes and biohackers often discuss it for endurance and fat-burning possibilities. The dual appeal of performance enhancement and metabolic health keeps it widely discussed.

It is followed because it targets Rev-Erb proteins, which regulate energy, fat storage, and circadian rhythm.
Interest is high due to suggestions it may simulate exercise-like effects in cells.
Its non-stimulant fat metabolism effects attract those wary of typical stimulants.
Uncertainty about safety and human trial data drives both caution and demand for more research.

It is followed because it targets Rev-Erb proteins, which regulate energy, fat storage, and circadian rhythm.
Interest is high due to suggestions it may simulate exercise-like effects in cells.
Its non-stimulant fat metabolism effects attract those wary of typical stimulants.
Uncertainty about safety and human trial data drives both caution and demand for more research.

SR9009: FACTS

Role	Endurance, metabolism, circadian rhythm modulation
Form & Classification	Rev-Erbα agonist, metabolic modulator
Research Status	Animal studies promising; no human clinical trials
Sources	Research chemical
Risk Profile & Monitoring	Unknown safety, may disrupt circadian biology if misused

What Is SR9009 – Stenabolic?

SR9009 – Stenabolic is a synthetic compound that activates REV-ERB proteins, influencing metabolism and circadian rhythm.

SR9009, also known as Stenabolic, is a synthetic compound that interacts with Rev-Erb proteins involved in circadian rhythm and metabolism. It is often described as a “exercise mimetic” in animal research, improving endurance and fat metabolism. Human studies are lacking, and safety is unknown. Its effects in animals suggest potential but untested benefits in humans. Without clinical data, its risks remain unclear.

SR9009 affects how the body manages energy at the cellular level.
Animal studies show increased stamina and reduced fat storage.
It has not undergone human clinical trials to confirm these findings.
Because it alters circadian biology, long-term impacts are unpredictable.

SR9009 affects how the body manages energy at the cellular level.
Animal studies show increased stamina and reduced fat storage.
It has not undergone human clinical trials to confirm these findings.
Because it alters circadian biology, long-term impacts are unpredictable.

What Does SR9009 – Stenabolic Do?

SR9009 affects circadian rhythm and metabolism by activating Rev-Erb proteins, which regulate fat storage, glucose use, and energy expenditure.

SR9009 (Stenabolic) affects circadian rhythm and metabolic processes. It activates Rev-Erb proteins, which regulate fat storage, glucose use, and daily energy cycles. By influencing these, it shifts how the body uses fuel, promoting fat burning and endurance. It also interacts with pathways involved in inflammation and cholesterol regulation. These effects give it wide appeal in metabolism research.

It improves energy use by making muscles rely more on stored fat for fuel.
It regulates the circadian clock, impacting sleep-wake and metabolic cycles.
It lowers blood fat and sugar levels in animal studies, suggesting cardiometabolic potential.
Its anti-inflammatory actions make it relevant in chronic disease research.

It improves energy use by making muscles rely more on stored fat for fuel.
It regulates the circadian clock, impacting sleep-wake and metabolic cycles.
It lowers blood fat and sugar levels in animal studies, suggesting cardiometabolic potential.
Its anti-inflammatory actions make it relevant in chronic disease research.

How Is SR9009 Used in Biohacking?

SR9009 is used in biohacking to boost endurance and fat burning by altering circadian and metabolic regulation.

SR9009 (Stenabolic) is used in biohacking for endurance and fat metabolism. Some describe it as an “exercise mimetic” because it influences energy usage at the cellular level. It is used to extend stamina or promote leaner body composition. Biohackers are drawn to its potential circadian benefits as well. Its experimental status keeps it limited to niche use.

It is applied to improve endurance during training without stimulant effects.
Biohackers use it to promote fat use as a fuel source for workouts.
It attracts attention for possible sleep and circadian rhythm optimization.
Its appeal lies in being non-hormonal yet metabolism-focused.

It is applied to improve endurance during training without stimulant effects.
Biohackers use it to promote fat use as a fuel source for workouts.
It attracts attention for possible sleep and circadian rhythm optimization.
Its appeal lies in being non-hormonal yet metabolism-focused.

Descriptions of protocols are provided to explain research methods only. They are not instructions for personal use. Individuals should not adapt or perform study procedures outside approved research settings with qualified supervision.

How Is SR9009 Used in Research Settings?

SR9009 is used in research to study circadian rhythm regulation, metabolism, and endurance.

SR9009 (Stenabolic) is used in research settings for metabolism and circadian rhythm regulation. It is tested in animals for fat burning, endurance, and cholesterol reduction. Studies examine how it activates Rev-Erb proteins to regulate energy balance. Researchers explore whether it can mimic exercise benefits at a cellular level. Human data is lacking, so work remains mostly preclinical.

Animal studies show improved endurance and fat metabolism when Rev-Erb pathways are activated.
It is tested for lowering blood fat and sugar levels linked to metabolic health.
Researchers examine circadian rhythm regulation to address sleep and energy disorders.
Studies remain preclinical, with human applications yet to be validated.

Animal studies show improved endurance and fat metabolism when Rev-Erb pathways are activated.
It is tested for lowering blood fat and sugar levels linked to metabolic health.
Researchers examine circadian rhythm regulation to address sleep and energy disorders.
Studies remain preclinical, with human applications yet to be validated.

How Fast Does SR9009 Work?

SR9009 acts quickly at a cellular level, but visible endurance and fat-loss effects are studied over several weeks.

SR9009 (Stenabolic) is reported to act quickly at the cellular level in animals. Endurance and fat-burning benefits are seen within days of consistent dosing in studies. Because it influences metabolism directly, some changes occur faster than structural muscle growth compounds. However, full benefits require longer use with regular training. Its onset is faster than many longevity agents but slower than stimulants.

Metabolism changes begin rapidly as Rev-Erb pathways activate in cells.
Animal studies show endurance improvements within a few days of use.
Fat metabolism effects appear quickly but need sustained intake for maintenance.
Results compound over weeks, especially when combined with exercise.

Metabolism changes begin rapidly as Rev-Erb pathways activate in cells.
Animal studies show endurance improvements within a few days of use.
Fat metabolism effects appear quickly but need sustained intake for maintenance.
Results compound over weeks, especially when combined with exercise.

Is SR9009 Safe?

SR9009 risks include liver strain and unknown long-term human effects since it has not been tested clinically.

SR9009 (Stenabolic) carries risks since most data comes from animal studies, not humans. Potential liver toxicity and metabolic strain are concerns. Because it alters circadian rhythm, sleep disruption may occur. Its lack of clinical trials makes side effects unpredictable. Using it outside research settings carries high uncertainty.

Liver function may be stressed by metabolism changes seen in animal models.
Sleep cycles may be disrupted by its action on circadian rhythm regulators.
Unknown long-term risks exist due to lack of human safety data.
Immune and metabolic impacts require further study before safe use is confirmed.

Liver function may be stressed by metabolism changes seen in animal models.
Sleep cycles may be disrupted by its action on circadian rhythm regulators.
Unknown long-term risks exist due to lack of human safety data.
Immune and metabolic impacts require further study before safe use is confirmed.

Small or early studies can overlook important risks, including organ effects and drug–substance interactions. Product quality outside research supply chains is uncertain. Individuals should not conduct at-home trials; participation should occur only within approved research or clinical care.

What Is the Most Common Form of SR9009?

SR9009 is most commonly available as injectable solution in research settings.

SR9009 (Stenabolic) is most commonly available as an injectable solution in research settings. This bypasses digestion and delivers it directly into circulation. Oral versions exist but have low bioavailability, making them less effective. Injectable form ensures more reliable results in lab studies. Its experimental nature means no standardized form is approved.

Injectable solutions dominate due to poor oral absorption rates.
Oral forms are unreliable and often require very high doses.
Research protocols favor injection for consistent biological effects.
No approved pharmaceutical version exists for human use.

Injectable solutions dominate due to poor oral absorption rates.
Oral forms are unreliable and often require very high doses.
Research protocols favor injection for consistent biological effects.
No approved pharmaceutical version exists for human use.

What Are Key Ingredients of SR9009?

SR9009 key ingredient is a synthetic molecule that activates Rev-Erb proteins.

SR9009 (Stenabolic) formulations rely on the SR9009 molecule as the key ingredient. It is a synthetic activator of Rev-Erb proteins. Research-grade solutions often include solvents for delivery but they are inactive. No secondary active agents are combined with it. The synthetic molecule itself provides all metabolic effects.

Active ingredient is SR9009, a lab-designed Rev-Erb activator.
Solutions may contain solvents like DMSO, which are inactive carriers.
Capsules or powders are standardized only with inert fillers.
The compound itself drives circadian and metabolic effects.

Active ingredient is SR9009, a lab-designed Rev-Erb activator.
Solutions may contain solvents like DMSO, which are inactive carriers.
Capsules or powders are standardized only with inert fillers.
The compound itself drives circadian and metabolic effects.

Is SR9009 Naturally Available in Food?

SR9009 is not naturally present in food as it is a synthetic molecule.

SR9009 (Stenabolic) is not naturally present in food. It is a fully synthetic compound designed to activate specific proteins. No plants or animals provide it in dietary form. Normal nutrition cannot contribute to its intake. It remains limited to laboratory synthesis.

No food sources contain SR9009.
It was designed in research labs as a Rev-Erb activator.
It does not occur as a metabolite in human diets.
Only experimental synthesis provides access to it.

No food sources contain SR9009.
It was designed in research labs as a Rev-Erb activator.
It does not occur as a metabolite in human diets.
Only experimental synthesis provides access to it.

Does SR9009 Impact Longevity?

SR9009 may impact longevity in theory by affecting circadian rhythm and metabolism, but human data is missing.

SR9009 (Stenabolic) may indirectly affect longevity by improving metabolism. Animal studies suggest better endurance, fat control, and reduced inflammation. However, no direct lifespan extension studies exist. Its experimental status leaves many unknowns about safety. It is not yet considered a reliable longevity compound.

SR9009 supports healthier metabolism, which is tied to aging resilience.
It reduces inflammation in animal models, potentially aiding healthspan.
No direct evidence connects it to longer lifespan in any species.
Unknown risks may outweigh benefits for long-term use.

SR9009 supports healthier metabolism, which is tied to aging resilience.
It reduces inflammation in animal models, potentially aiding healthspan.
No direct evidence connects it to longer lifespan in any species.
Unknown risks may outweigh benefits for long-term use.

Does Tolerance Develop for SR9009?

SR9009 tolerance is possible since it acts on circadian and metabolic pathways, but not well studied in humans.

SR9009 (Stenabolic) has limited data on tolerance development. Some animal research suggests effects diminish if used continuously. This may result from receptor pathway adaptation over time. Cycling or intermittent dosing is sometimes suggested in experimental use. Human tolerance data does not yet exist.

Animal models show declining effects with continuous exposure.
Potential tolerance relates to receptor adaptation in circadian regulation.
Cycling is suggested by researchers to maintain effectiveness.
No human studies confirm or deny tolerance development yet.

Animal models show declining effects with continuous exposure.
Potential tolerance relates to receptor adaptation in circadian regulation.
Cycling is suggested by researchers to maintain effectiveness.
No human studies confirm or deny tolerance development yet.

Short, controlled tests do not establish long-term safety or cumulative effects. This information is for context, not for ongoing personal use. Exposure to experimental substances should not occur outside clinically supervised tests.

Do SR9009 Effects Persist?

SR9009 effects on metabolism and endurance disappear quickly after discontinuation.

SR9009 (Stenabolic) effects stop quickly after discontinuation. Endurance and metabolism support decline within days. Its action on Rev-Erb proteins requires continuous presence of the compound. No evidence shows permanent adaptations from its use. Effects are short-lived and reversible.

Endurance and fat metabolism improvements fade once dosing ends.
Benefits depend on active stimulation of Rev-Erb pathways.
No lasting exercise-mimicking effects remain after withdrawal.
It functions as a transient metabolism modulator.

Endurance and fat metabolism improvements fade once dosing ends.
Benefits depend on active stimulation of Rev-Erb pathways.
No lasting exercise-mimicking effects remain after withdrawal.
It functions as a transient metabolism modulator.

Signals that look promising in a lab may not hold up in broader populations and may reveal risks later. This information is explanatory only and does not support self-directed use to “reproduce” results.

How Long Do SR9009’s Side Effects and Traces Persist?

SR9009 side effects and traces clear within a day or two, but long-term effects are not well studied.

SR9009 (Stenabolic) traces do not persist long, but data is limited. Animal studies suggest rapid clearance within hours. Side effects such as disrupted sleep would fade quickly. It does not appear to accumulate in tissues. Effects stop soon after withdrawal.

Animal data shows short half-life with fast elimination.
Sleep disruption resolves once dosing ends.
No strong evidence for long-term buildup exists.
Its transient action ends within hours to days.

Animal data shows short half-life with fast elimination.
Sleep disruption resolves once dosing ends.
No strong evidence for long-term buildup exists.
Its transient action ends within hours to days.

Early reports may miss rare, delayed, or interaction-related harms. This section explains study observations only and does not justify anyone trying the substance. Individuals should stop and seek care for concerning symptoms and should not self-experiment.

Is SR9009 a Regulated Substance?

SR9009 is a regulated research chemical and not approved for human use.

SR9009 (Stenabolic) is not approved for human use and is sold only as a research chemical. It is banned in sports by the World Anti-Doping Agency. No country approves it as a supplement or drug for the public. Regulation is strict due to lack of safety data. Its use remains experimental and prohibited outside labs.

It is banned in competitive sports as a performance-enhancing agent.
No supplement or drug approval exists globally.
Its use is restricted to laboratory research.
Public access is limited to unofficial experimental markets.

It is banned in competitive sports as a performance-enhancing agent.
No supplement or drug approval exists globally.
Its use is restricted to laboratory research.
Public access is limited to unofficial experimental markets.

Legal status, import rules, and anti-doping policies vary and change. Clinical study access does not imply personal use is permitted. Verify current rules with relevant authorities; do not proceed outside them.

When Was SR9009 First Used?

SR9009 was first developed in 2012 as a Rev-Erb agonist for circadian rhythm research.

SR9009 (Stenabolic) was first developed in 2012. It was designed as a synthetic activator of Rev-Erb proteins. Early research explored its effects on circadian rhythm and metabolism in animals. It quickly attracted interest for endurance and fat metabolism studies. Since then, it has remained a laboratory research compound.

Developed in 2012 as part of circadian rhythm research projects.
Created to test synthetic activation of Rev-Erb receptors.
Animal studies revealed metabolism and endurance benefits.
Never advanced into approved human drug development.

Developed in 2012 as part of circadian rhythm research projects.
Created to test synthetic activation of Rev-Erb receptors.
Animal studies revealed metabolism and endurance benefits.
Never advanced into approved human drug development.

What Additional Research Is Needed on SR9009?

SR9009 needs human trials to confirm metabolism, endurance effects, and safety.

SR9009 (Stenabolic) research needs human clinical trials. Current evidence is limited to animal and cell studies. Its poor oral bioavailability must be solved for practical use. Long-term safety data is completely absent. Research should explore whether circadian and metabolic benefits apply in humans.

Human trials are the most urgent research gap for SR9009.
Bioavailability improvements are needed for oral effectiveness.
Safety studies must confirm absence of liver and metabolic toxicity.
Impact on human circadian rhythm and endurance remains untested.

Human trials are the most urgent research gap for SR9009.
Bioavailability improvements are needed for oral effectiveness.
Safety studies must confirm absence of liver and metabolic toxicity.
Impact on human circadian rhythm and endurance remains untested.

What Links SR9009 Research to Myostatin?

SR9009 research links to myostatin via potential effects on metabolic genes controlling muscle repair.

SR9009 research focuses on metabolic clocks, and any link to myostatin is speculative. Myostatin controls muscle growth limits, while SR9009 studies examine energy use. The two areas overlap because metabolism and muscle maintenance share regulatory signals. No study has confirmed direct myostatin changes. The connection is discussed only in theory.

Metabolic pathways affect muscle tissue indirectly through energy regulation.
Clock proteins studied with SR9009 influence activity cycles, not myostatin directly.
Growth signaling interacts with metabolism but remains separate from proven effects.
Evidence gaps keep the link unconfirmed.

Metabolic pathways affect muscle tissue indirectly through energy regulation.
Clock proteins studied with SR9009 influence activity cycles, not myostatin directly.
Growth signaling interacts with metabolism but remains separate from proven effects.
Evidence gaps keep the link unconfirmed.

Myostatin Inhibitors: What They Are, Research, and Risks

How Do Studies Compare Turkesterone?

Studies compare Turkesterone by examining strength gains and hormonal neutrality.

Studies compare turkesterone by looking at strength, mass, and performance markers. Some trials place it against placebo groups. Others compare it with training-only programs. Variability in methods shapes conclusions. Most comparisons show small differences.

Placebo control helps clarify true effects.
Training-only groups show baseline change.
Strength metrics serve as primary endpoints.
Lean mass scans add objectivity.
Outcome differences often remain minimal.

Placebo control helps clarify true effects.
Training-only groups show baseline change.
Strength metrics serve as primary endpoints.
Lean mass scans add objectivity.
Outcome differences often remain minimal.

Turkesterone: Benefits, Side Effects, and Dosage

Subcutaneous Fat: What It Is, Health Effects, and How to Reduce

Spirulina: Benefits, Side Effects, and Dosage

Biohacking involves significant health risks, including potential disruption of normal body processes, interference with medications, and interactions with underlying medical conditions. The use of experimental substances—even when not currently banned or regulated—can have unpredictable and possibly long-term effects. Even where small human trials have reported encouraging short-term outcomes, the broader and long-term safety profiles often remain anecdotal or unverified. Myopedia recognizes the increasing attention toward biohacking and emerging longevity or performance technologies. These articles are intended to inform and encourage understanding of scientific developments, not to promote personal experimentation or unsupervised use.
Information about applications, case studies, or trial data is presented for educational purposes only, may contain inaccuracies or omissions, and should not be used to guide the use of any substance, method, or routine.

Medical Disclaimer: All content on this website is intended solely for informational and educational purposes and should not be interpreted as a substitute for professional medical advice, diagnosis, or treatment, nor as encouragement or promotion for or against any particular use, product, or activity. Results may vary and are not guaranteed. No doctor–patient relationship is created by your use of this content. Always consult a qualified healthcare provider, nutritionist, or other relevant expert before starting or changing any supplement, diet, exercise, or lifestyle program. This website can contain errors. Check important information. Read our full Disclaimer.

Status – Terms of Service – Privacy Policy – Disclaimer – About Myopedia.